Stocks · Health care · Pharmaceutical Preparations

ARDELYX, INC.

ARDX Clue Score56
United States Fiscal year ends December CIK 0001437402 Results filed 3 Nov 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Michael Raab
15 Jul 2026
President & CEO
Sold after exercise
41,668
$5.06
$210.92K
Laura A Williams
18 Jun 2026
Chief Patient Officer
Sold after exercise
81,898
$5.99
$490.49K
Michael Raab
15 Jun 2026
President & CEO
Sold after exercise
41,666
$5.67
$236.35K
Michael Raab
15 May 2026
President & CEO
Sold after exercise
41,666
$6.28
$261.61K
Michael Raab
15 Apr 2026
President & CEO
Sold after exercise
41,668
$6.29
$261.95K
Michael Raab
16 Mar 2026
President & CEO
Sold after exercise
41,666
$5.84
$243.33K
Michael Raab
24 Feb 2026
President & CEO
Sold after exercise
41,666
$6.26
$260.62K
Laura A Williams
8 Jan 2026
Chief Patient Officer
Sold after exercise
50,000
$6.98
$348.90K

What was left out

Form 4 filings counted 54
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 8
Sales at will 70
Transactions with no price 0
Shares from compensation/vesting 1,549,407
History held since 18 Jun 2014